Karyopharm Therapeutics
KPTI
KPTI
86 hedge funds and large institutions have $239M invested in Karyopharm Therapeutics in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
+7
Holders Change %
+8.86%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
37
Reduced
17
Closed
6
Calls
$976K
Puts
$6K
Net Calls
+$970K
Net Calls Change
+$394K
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.92M |
| 2 |
Millennium Management
New York
|
-$1.51M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$433K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$265K |
| 5 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$203K |
